Call for Abstract

12th World Congress on Diabetes, will be organized around the theme “ Diabetes from Monitoring to Management”

Diabetes 2016 is comprised of 11 tracks and 83 sessions designed to offer comprehensive sessions that address current issues in Diabetes 2016.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Diabetes is one of the most significant global health concerns of modern times. The causes of type 2 diabetes are multi-factorial and include both genetic and environmental elements that affect beta-cell function and tissue (muscle, liver, adipose tissue, and pancreas) insulin sensitivity. A number of factors have been suggested as possibly linking insulin resistance and beta-cell dysfunction in the pathogenesis of Type 2 Diabetes. A majority of individuals suffering from type 2 diabetes are obese, with central visceral adiposity. According to the International Diabetes Federation, diabetes statistics says that there are more than 317 million people have been diagnosed with diabetes, and an additional 187 million are living undiagnosed. The global revenue earned from drugs sales to treat Type 2 Diabetes was approximately $36.89 billion in 2012 that is rapidly increasing in incidence and prevalence across the globe predicated to elevate this figure to approximately $68.42 billion by 2017. Patients with this disease cannot use glucose properly for their body needs. Latest research on Diabetes has led to the better living of the diabetic patients. In addition to this, self-monitoring of Blood glucose levels, lifestyle modifications and health eating habits are crucial in combating the critical manifestations of this disease which may require proper diabetic nursing. This may also include considerable amount of time educating patients and families on proper dietary, exercise and lifestyle habits to keep symptoms under control.

  • Track 1-1Beta cell and Aging
  • Track 1-2Role of non-beta cells in glucose homeostasis
  • Track 1-3Role of DNA methylation in insulin secretion
  • Track 1-4Genetic defects in insulin action
  • Track 1-5Diabetes in specific ethnic groups

Novel therapeutic targets available for diabetes includes Incretin based therapies, oral therapeutic agents like secretagogues, beta cell regeneration & proliferation and stem cell therapies.  Embryonic stem cell and fetal precursor cell transplantation therapies are the major stem cell therapies available for Diabetes. Apart from the above, various computational approaches in Diabetes management have been introduced recently with latest diabetes clinical trial going on which are playing an important role in identification of genes causing diabetes helping in Early Detection of Diabetes. These processes are also useful in studying the chemical etiologies of Diabetes uncovering various treatment prospects and model construction processes for survival prediction combating the complications of diabetes like Gestational Diabetes, Diabetes Myopathy, Diabetes cardiopathy and more.

  • Track 2-1Recent advances in Diabetic drugs
  • Track 2-2Continuous Glucose Monitoring
  • Track 2-3Pharmacotherapy
  • Track 2-4Artificial and bio-artificial pancreas
  • Track 2-5Anti- diabetic agents
  • Track 2-6Pharmaceutical Drugs for Sugar control
  • Track 2-7Human Insulins and Analogues
  • Track 2-8Novel Paradigms in diabetes
  • Track 2-9Bariatric surgery & obesity
  • Track 2-10Antidiabetic medicines or drugs
  • Track 2-11Insulin pump and its development

With rising numbers of diagnosed diabetics, pharmaceutical manufacturers have capitalized on the burgeoning market for diabetes therapies. Manufacturers' efforts to develop non-invasive methods of insulin delivery are set to revolutionize the insulin therapy market, while demand for oral medications is on the upswing due to a growing Type 2 diabetic population and introduction of technologically advanced therapies for battling complications associated to Type 2 Diabetes like the most prevalent Diabetes Cardiomyopathy. With human embryonic stem cells as a starting point, the scientists are for the first time able to produce, in the kind of massive quantities needed for cell transplantation and pharmaceutical purposes, human insulin-producing beta cells equivalent in most every way to normally functioning beta cells. This will certainly help people recover the prognosis of the fatal disease like diabetes.

  • Track 3-1Clinical Trials and New biomarkers under development
  • Track 3-2Biostator: closed loop system
  • Track 3-3Development of artificial Beta cells and pancreas
  • Track 3-4Continuous Glucose Monitoring
  • Track 3-5New drug treatments and devices for diabetes
  • Track 3-6Development of insulin pump
  • Track 3-7Pharmacotherapy in treatment of diabetes
  • Track 3-8Inflammatory markers and Type 2 diabetes
  • Track 3-9Molecular Markers for both metabolic syndrome and Hypoglycemia Responses
  • Track 3-10Development of Insulin Pens and Novel Insulin Delivery technique

The global diabetes treatment market is undergoing significant transition driven by the advent of new analytical technologies and developments in diabetes treatment. There has been a drastic increase in the incidents of diabetes worldwide, owing to the rising level of lifestyles and obesity in global population. The diabetes treatment products include injectable diabetes drugs, oral drugs, insulin therapies, insulin pumps, insulin injection devices and blood glucose monitoring systems which eliminates the risk of reverse diabetes. According to the new report the world market for diabetes medications will reach $55.3bn in 2017. The anti-diabetic medicines industry generated $35.6bn in 2012, and its revenues will show strong growth to 2023. Monitoring glucose levels is critical for the management of diabetes and new and improved portable, less costly, easy-to-use, accurate and virtually painless blood glucose monitoring systems are now available to take control of the disease.

  • Track 4-1Newer Diabetes Medications, TZDs, and Combinations
  • Track 4-2What is a Better Second-Line Agent After Metformin: DPP-4 Inhibitors or SGLT-2 Inhibitors?
  • Track 4-3MODY and its types
  • Track 4-4Weighing the Benefits and Risks of Diabetes Drugs
  • Track 4-5Genetics of Metabolic Syndrome
  • Track 4-6Second- and Third-Line Pharmacotherapy for Type 2 Diabetes
  • Track 4-7Endocrinopathies

Diabetes Mellitus is a dreadful disease and is found in all parts of the world, becoming a serious threat of mankind health. There are lots of chemical agents available to take control on the disease, but total recovery from diabetes is the question to the treatment. Alternative to these synthetic agents, natural cure by plants provides a potential source curing complications of hypoglycemia and reverse Diabetes are widely used in several traditional systems of medicine to prevent prediabetes. Other alternative therapies such as diabetic supplements, acupuncture, hydrotherapy, and yoga therapies are reported to have less likely side effects of conventional approaches for diabetes.

  • Track 5-1Diabetes: Type 1 and Type 2
  • Track 5-2Continuous Glucose MonitoringArtificial and bio-artificial pancreas
  • Track 5-3Glycemic load
  • Track 5-4Glycemic index
  • Track 5-5Neonatal Diabetes
  • Track 5-6Monogenic Forms of Diabetes
  • Track 5-7Paediatric diabetes
  • Track 5-8Immune Intervention diabetes
  • Track 5-9Prediabetes
  • Track 5-10Diabetes in children
  • Track 5-11Genetics of metabolic syndrome: Challenges and relation with Diabetes Mellitus
  • Track 5-12Idiopathic
  • Track 5-13Latent autoimmune diabetes of adults
  • Track 5-14Autoimmune Diabetes Mellitus
  • Track 5-15Gestational Hyperglycaemia and Diabetes
  • Track 5-16Neuropathic

Diabetes has increasingly become a lifestyle-related disease as it afflicts young and old. As the number of patients grows across the globe, there has never been a stronger and more urgent need for novel therapeutic measures in clinical and preclinical evaluation, that arrest the growth of the disease. The diabetes market, consisting mainly of Type 1 and Type 2 diabetes, is large and growing significantly. The global market value for diabetes therapies and diagnostics has reached to $48.5 billion. The largest segment of the market, insulin products, is worth $20.8 billion in the recent times, including administration and diagnostic devices. Monitoring devices and other related equipment, the second-largest market is established with an investment of $13.5 billion in which was proposed for $11.3. The fastest-growing segment of oral diabetic complication of hypoglycemia drugs manufacturing funding is $14.13 in present scenario of diabetes market.

  • Track 6-1Non-invasive diagnostic tool and imaging of Diabetes
  • Track 6-2Clinical diagnosis and laboratory tests
  • Track 6-3Prediabetes, anti-diabetes and metabolic syndrome
  • Track 6-4Hypoglycemia Awareness
  • Track 6-5Herbs, Supplements and Alternative Medicines
  • Track 6-6Yoga and diabetes
  • Track 6-7Nutrion Therapy
  • Track 6-8Reverse Diabetes
  • Track 6-9Carbohydrate counting

With the growing awareness and information regarding preventive measures for combating fatal disease like diabetes, consumers are opting for proper food along with medicines. One can improve the health in a big way by making small changes to the diet, while still enjoying the favorite foods and taking pleasure from the meals. A diabetes diet is simply a healthy eating plan that is high in nutrients, low in fat, and moderate in calories. Manufacturers are now keen towards Diabetes Nutrition on introducing new low calorie food products with sugar substitutes and less oil, in view of the increasing consumer interest toward healthy eating and help prevent diabetes and its concomitant risk factors.

  • Track 7-1Frontiers in the Diabetic Nutrition
  • Track 7-2Association between Alcohol Consumption and Glycemic Status
  • Track 7-3Non-Pharmacological Interventions to Reduce the Risk of Diabetes in People with Impaired Glucose Regulation
  • Track 7-4Management of Inpatient Hyperglycemia
  • Track 7-5Diabetic Diets for Frail Elderly Long-Term Care Residents with Type II Diabetes Mellitus
  • Track 7-6Diet for Diabetes in Pregnancy
  • Track 7-7Impact of food & nutrition in diabetes management
  • Track 7-8Advanced nutrition and dietetics in diabetes

Current Research in diabetes is focusing on developing Implantable insulin pumps which introduced Insulin pump therapy, disruption of fat metabolism, invasive and non-invasive glucose sensors, Artificial pancreas, New insulin delivery systems like inhaled, transdermal and implantable devices, Insulin Pens, Bariatric surgery and Conventional therapeutic approaches. Traditional approaches like Acupuncture and herbal medications are playing vital role in treatment of Diabetes and its related risk factors covering majorly obesity and Diabetes.

  • Track 8-1Lifestyle Interventions for Type 2 Diabetes Conditions
  • Track 8-2Cardiovascular Considerations in Type 2 Diabetes
  • Track 8-3Hyperglycemic Emergencies in Adults
  • Track 8-4 Diabetes from Monitoring to Management
  • Track 8-5projection of prevalence and cost of diabetes in Canada
  • Track 8-6 Development of Non-invasive Diagnostic Device for Diabetes
  • Track 9-1Energy balance and Obesity
  • Track 9-2Genetics of metabolic syndrome: Challenges and relation with Diabetes Mellitus
  • Track 9-3Beta cell regeneration & encapsulation research
  • Track 9-4Genetic Defects of Beta Cell Function
  • Track 9-5New insights into beta cell signaling pathways
  • Track 9-6The Canadian Diabetes Risk Assessment Questionnaire (CANRISK)
  • Track 10-1Behavioral Programs for Diabetes Mellitus
  • Track 10-2Depressive Symptoms in Patients with Type 2 Diabetes
  • Track 10-3Tai chi practice in diabetes
  • Track 10-4Recurrent Depressive Disorder and Diabetes
  • Track 10-5Mobile & IT Technologies for patients